For research use only. Not for therapeutic Use.
5-(Hydroxymethyl)cytidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Catalog Number | R020937 |
CAS Number | 19235-17-7 |
Synonyms | 4-amino-1-[(2R,3S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(hydroxymethyl)pyrimidin-2-one |
Molecular Formula | C10H15N3O6 |
Purity | ≥95% |
InChI | InChI=1S/C10H15N3O6/c11-8-4(2-14)1-13(10(18)12-8)9-7(17)6(16)5(3-15)19-9/h1,5-7,9,14-17H,2-3H2,(H2,11,12,18)/t5-,6?,7+,9-/m1/s1 |
InChIKey | NFEXJLMYXXIWPI-AOXOCZDOSA-N |
SMILES | C1=C(C(=NC(=O)N1C2C(C(C(O2)CO)O)O)N)CO |
Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |